Review

Published on 28 Nov 2024

Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models

in Gastrointestinal and Hepatic Pharmacology

Xiao Hong
Shuo Huang
He Jiang
Qing Ma
Jiang Qiu
Qihan Luo
Chunlu Cao
Yiyang Xu
Fuzhe Chen
Yufan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1432480

Original Research

Accepted on 27 Nov 2024

Polysaccharides Derived from Golden Mushroom (Cantharellus cibarius Fr.) Modulate Gut Microbiota and Enhance Intestinal Barrier Function to Ameliorate Dextran Sulfate Sodium-Induced Colitis in Mice

in Gastrointestinal and Hepatic Pharmacology

Yamina ALIOUI
Hidayat Ullah
Sharafat Ali
Mujeeb Ur Rahman
Maroua Elkharti
Nabeel Ahmed Farooqui
Ata Ur Rehman
Muhammad Ilyas
Duaa M Alsholi
Nimra Zafar Siddiqui

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498625

Editorial

Accepted on 25 Nov 2024

Editorial: Unraveling the role of gut pathogens in microbiome dysbiosis and the associated health implications and therapeutic strategies

in Gastrointestinal and Hepatic Pharmacology

Imran Khan
Huang Gouxin
Shafia Khan
Abid Ali

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1513694

Editorial

Accepted on 25 Nov 2024

Editorial: Leveraging multi-omics approaches to understand and manage gastrointestinal and hepatic diseases

in Gastrointestinal and Hepatic Pharmacology

Isis Trujillo-Gonzalez
Paul G Thomes
Isin Tuna Sakallioglu
Kusum K. Kharbanda

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1529088

Original Research

Published on 25 Nov 2024

Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system

in Gastrointestinal and Hepatic Pharmacology

Zhiyuan Zhang
Yifan Yao
Li Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1500810

137 views

Original Research

Published on 25 Nov 2024

Osteopontin neutralization increases vitamin D receptors on NKT cells and ameliorates liver fibrosis by promoting their activity

in Gastrointestinal and Hepatic Pharmacology

Johnny Amer
Ahmad Salhab
Enas Hussini
Rasha Shweiki
Iman Zahran
Mohammad Far

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1484278

152 views

Original Research

Published on 22 Nov 2024

p-hydroxy benzaldehyde attenuates intestinal epithelial barrier dysfunction caused by colitis via activating the HNF-1β/SLC26A3 pathway

in Gastrointestinal and Hepatic Pharmacology

Meng Liu
Yuhui Wang
Xiaotian Xu
Guoqiang Guan
Shu Zhang
Shengnan Zhu
Yang Liu
Yizhun Zhu
Xiaoqun Duan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1448863

204 views

Original Research

Published on 21 Nov 2024

ADRB2 serves as a novel biomarker and attenuates alcoholic hepatitis via the SIRT1/PGC-1α/PPARα pathway: integration of WGCNA, machine learning and experimental validation

in Gastrointestinal and Hepatic Pharmacology

Li Song
Shuo Huang
Honghao Yan
Qing Ma
Qihan Luo
Jiang Qiu
Minxia Chen
Zongyuan Li
He Jiang
Yufan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1423031

299 views

Original Research

Published on 20 Nov 2024

Integrated multi-omics analyses combined with western blotting discovered that cis-TSG alleviated liver injury via modulating lipid metabolism

in Gastrointestinal and Hepatic Pharmacology

Tekleab Teka
Jiang Wu
Patrick Kwabena Oduro
Ze Li
Chenxi Wang
Hao Chen
Lin Zhang
Haitao Wang
Liming Wang
Lifeng Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485035

315 views

Original Research

Accepted on 14 Nov 2024

Nitazoxanide mitigates methotrexate hepatotoxicity in rats: role in inhibiting apoptosis and regulating endoplasmic reticulum stress

in Gastrointestinal and Hepatic Pharmacology

Nevertyty Mohamed Mahmoud
Shimaa Elshazly
Fatma El-Shaarawy
Sawsan A Zaitone
Afaf Aldahish
Gehan A Ahmed
Manal S Fawzy
Sheka Aloyouni
Sally Abed
Shaimaa S El-Sayed

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491249

Original Research

Accepted on 14 Nov 2024

Effect of Helicobacter pylori-Related Chronic Gastritis on Gastrointestinal Microorganisms and Brain Neurotransmitters in Mice

in Gastrointestinal and Hepatic Pharmacology

Hai-Hua Liu
Tang-Tang Lin
Qi-Jia Zhang
Ling Zhang
Jin-Ying Fang
Ling Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1472437

Original Research

Published on 13 Nov 2024

Tracing the historical foundations of infliximab in Crohn’s disease treatment: a cited reference analysis

in Gastrointestinal and Hepatic Pharmacology

Andy Wai Kan Yeung

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498464

129 views

Original Research

Published on 13 Nov 2024

Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis

in Gastrointestinal and Hepatic Pharmacology

Hui Guo
Qian Guo
Zhiqiang Li
Ze Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1461398

256 views

Original Research

Published on 08 Nov 2024

Celecoxib and rofecoxib have different effects on small intestinal ischemia/reperfusion injury in rats

in Gastrointestinal and Hepatic Pharmacology

Szilvia B. László
Barbara Hutka
András S. Tóth
Tamás Hegyes
Zsuzsanna O. Demeter
Arezoo Haghighi
Gerda Wachtl
Ágnes Kelemen
Anna Jakab
Klára Gyires

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1468579

293 views

Clinical Trial

Published on 08 Nov 2024

Comparison of enteral prucalopride versus intravenous metoclopramide for feeding intolerance in patients with critical illness: a randomized double-blinded study

in Gastrointestinal and Hepatic Pharmacology

Eman Mohamed Elmokadem
Dina Khaled Abou El Fadl
Nermin Eissa
Najla Abdulaziz Alnassar
Ahmed M. Bassiouny
Amir Eskander Hanna Samy
Nouran Omar El Said

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413246

242 views

Original Research

Published on 07 Nov 2024

Rabeprazole suppressed gastric intestinal metaplasia through activation of GPX4-mediated ferroptosis

in Gastrointestinal and Hepatic Pharmacology

Jing Xie
Xinhua Liang
Fangfang Xie
Canxin Huang
Zijun Lin
Shuping Xie
Fangying Yang
Fengfeng Zheng
Lanlan Geng
Wanfu Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1409001

369 views

Navigation group

Articles

Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models

Polysaccharides Derived from Golden Mushroom (Cantharellus cibarius Fr.) Modulate Gut Microbiota and Enhance Intestinal Barrier Function to Ameliorate Dextran Sulfate Sodium-Induced Colitis in Mice

Editorial: Unraveling the role of gut pathogens in microbiome dysbiosis and the associated health implications and therapeutic strategies

Editorial: Leveraging multi-omics approaches to understand and manage gastrointestinal and hepatic diseases

Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system

Osteopontin neutralization increases vitamin D receptors on NKT cells and ameliorates liver fibrosis by promoting their activity

p-hydroxy benzaldehyde attenuates intestinal epithelial barrier dysfunction caused by colitis via activating the HNF-1β/SLC26A3 pathway

ADRB2 serves as a novel biomarker and attenuates alcoholic hepatitis via the SIRT1/PGC-1α/PPARα pathway: integration of WGCNA, machine learning and experimental validation

Integrated multi-omics analyses combined with western blotting discovered that cis-TSG alleviated liver injury via modulating lipid metabolism

Nitazoxanide mitigates methotrexate hepatotoxicity in rats: role in inhibiting apoptosis and regulating endoplasmic reticulum stress

Effect of Helicobacter pylori-Related Chronic Gastritis on Gastrointestinal Microorganisms and Brain Neurotransmitters in Mice

Tracing the historical foundations of infliximab in Crohn’s disease treatment: a cited reference analysis

Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis

Celecoxib and rofecoxib have different effects on small intestinal ischemia/reperfusion injury in rats

Comparison of enteral prucalopride versus intravenous metoclopramide for feeding intolerance in patients with critical illness: a randomized double-blinded study

Rabeprazole suppressed gastric intestinal metaplasia through activation of GPX4-mediated ferroptosis